Related Experiment Videos

Leukocyte-endothelial interactions and organ injury: the role of adhesion molecules

G A Talbott1, S R Sharar, J M Harlan

  • 1Department of Anesthesiology, University of Washington School of Medicine, Seattle 98104.

New Horizons (Baltimore, Md.)
|November 1, 1994
PubMed

Insights

Polymorphonuclear neutrophils (PMNs) are crucial for host defense but can cause injury during severe inflammation. Understanding PMN-endothelial adherence via adhesion molecules is key to preventing tissue damage and exploring therapeutic blockade.

Area of Science:

  • Immunology
  • Cell Biology
  • Vascular Biology

Background:

  • Polymorphonuclear neutrophils (PMNs) are vital for host defense but can cause significant tissue injury during excessive inflammation.
  • Uncontrolled PMN adherence to the microvascular endothelium is a key mechanism in critical illness-related organ damage.
  • PMN-endothelial interactions are mediated by specific adhesion molecules, including beta 2 integrins and selectins.

Purpose of the Study:

  • To review the molecular mechanisms underlying PMN-endothelial cell adherence.
  • To examine in vivo models demonstrating the protective effects of adhesion molecule blockade against injury.
  • To briefly discuss the role of adhesion molecules in T-lymphocyte function and transplant rejection, and review associated infectious risks.

Main Methods:

  • Literature review focusing on the molecular basis of PMN-endothelial adherence.
  • Analysis of in vivo experimental models investigating adhesion molecule blockade.
  • Examination of studies on T-lymphocyte adhesion and infectious risks of therapeutic blockade.

Main Results:

  • PMN-endothelial adherence involves beta 2 integrins and selectin families interacting with their ligands.
  • Adhesion molecule blockade has shown protective effects against tissue and organ injury in various in vivo models.
  • Adhesion molecules also influence T-lymphocyte adhesion, immune surveillance of allografts, and carry potential infectious risks.

Conclusions:

  • Adhesion molecules are critical regulators of PMN-endothelial interactions, impacting inflammatory injury.
  • Targeting adhesion molecules offers a potential therapeutic strategy for inflammatory conditions, with demonstrated efficacy in preclinical models.
  • Further research is warranted to balance the benefits of adhesion molecule blockade against potential infectious risks and effects on immune surveillance.

Related Concept Videos